adcirca.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /hcp/pdf Disallow: | ||
Meta Tags
| Title | ADCIRCA (tadalafil) tablets Once-daily treatment for |
| Description | MOVING FORWARD WITH ADCIRCA (tadalafil) ADCIRCA inhibits PDE-5, leading to increased cGMP levels, thereby increasing |
| Keywords | adcirca,adcirca cost,adcirca drug,adcirca adverse events,adcirca adverse reactions,adcirca side effects,cardio pulmonary hypertension,cardiopulmonary hypertension,idiopathic pulmonary arterial hypertension,idiopathic PAH,improvement in PAH treatment |
Server Information
| WebSite | |
| Host IP | 45.60.45.59 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
adcirca.com Valuation
|
US$9,873,261
Last updated: 2023-05-10 18:36:59
adcirca.com has Semrush global rank of 1,072,017. adcirca.com has an estimated worth of US$ 9,873,261, based on its estimated Ads revenue. adcirca.com receives approximately 1,139,223 unique visitors each day. Its web server is located in United States, with IP address 45.60.45.59. According to SiteAdvisor, adcirca.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$9,873,261 |
| Daily Ads Revenue | US$9,114 |
| Monthly Ads Revenue | US$273,414 |
| Yearly Ads Revenue | US$3,280,961 |
| Daily Unique Visitors | 75,949 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| adcirca.com. | A | 3599 | IP: 45.60.45.59 |
| adcirca.com. | A | 3599 | IP: 45.60.106.59 |
| adcirca.com. | NS | 86400 | NS Record: ns6.markmonitor.com. |
| adcirca.com. | NS | 86400 | NS Record: ns1.markmonitor.com. |
| adcirca.com. | NS | 86400 | NS Record: ns4.markmonitor.com. |
| adcirca.com. | NS | 86400 | NS Record: ns7.markmonitor.com. |
| adcirca.com. | NS | 86400 | NS Record: ns5.markmonitor.com. |
| adcirca.com. | NS | 86400 | NS Record: ns3.markmonitor.com. |
| adcirca.com. | NS | 86400 | NS Record: ns2.markmonitor.com. |
| adcirca.com. | TXT | 3600 | TXT Record: _globalsign-domain-verification=SJrg9FDh95JM20LiK-58daNLKSFH1hf-G3AkFTirIe |
| adcirca.com. | TXT | 3600 | TXT Record: app-adcirca.azurewebsites.net |
| adcirca.com. | TXT | 3600 | TXT Record: q86c316r7df2dr3sp7l6sfff5zldfm48 |
| adcirca.com. | TXT | 3600 | TXT Record: cljfbzpgmhl1mt0z1nczcjw7cc2p65vq |
HtmlToTextCheckTime:2023-05-10 18:36:59
| Skip Navigation Important Safety Information Full Prescribing Information Patient Information Healthcare Professionals For US Residents Only MOVING FORWARD WITH ADCIRCA (tadalafil) ONCE-DAILY PAH treatment that can help improve exercise ability ADCIRCA ® (tadalafil) is a prescription medication used to treat pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability. Studies establishing effectiveness included predominately patients with NYHA Functional Class II–III symptoms and etiologies of idiopathic or heritable PAH (61%) or PAH associated with connective tissue diseases (23%). Home About Adcirca About PAH Living PAH --> PAH Resources Financial Assistance How ADCIRCA works How ADCIRCA may help you How to take ADCIRCA ADCIRCA FAQs What is PAH? --> Causes of PAH Signs and symptoms of PAH Diagnosing PAH PAH organizations PAH community group --> Downloadable resources ADCIRCA Co-pay Assistance Program and tags, as close as possible to the opening tag. |
HTTP Headers
HTTP/1.1 301 Moved Permanently Location: https://adcirca.com/ Content-Length: 0 Connection: close HTTP/2 302 cache-control: private content-length: 136 content-type: text/html; charset=utf-8 location: /patient/index.aspx server: Microsoft-IIS/10.0 set-cookie: ASP.NET_SessionId=ekvxv1vmahsokkmko3kf1qoo; path=/; HttpOnly; SameSite=Lax x-aspnet-version: 4.0.30319 x-powered-by: ASP.NET set-cookie: ARRAffinity=49a94ddcdeb25346ee3a2b6c760ba69b1e208509e94f78fe226be7730ca067b6;Path=/;HttpOnly;Secure;Domain=adcirca.com set-cookie: ARRAffinitySameSite=49a94ddcdeb25346ee3a2b6c760ba69b1e208509e94f78fe226be7730ca067b6;Path=/;HttpOnly;SameSite=None;Secure;Domain=adcirca.com date: Wed, 03 Nov 2021 06:17:46 GMT set-cookie: visid_incap_2149016=TkLvT9cCQMaP3pOu6bcqh4spgmEAAAAAQUIPAAAAAADC18jJhmWFOtZRMoGVMEjE; expires=Wed, 02 Nov 2022 06:34:01 GMT; HttpOnly; path=/; Domain=.adcirca.com set-cookie: nlbi_2149016=mGlwe2OYIHGnB7p2ZIK6gQAAAADeR05N6uLeJef5OgNho0bj; path=/; Domain=.adcirca.com set-cookie: incap_ses_7221_2149016=5Pu9K1Ud4AvxShpUjyU2ZIspgmEAAAAAMC1dp8Xt5fJHPY2nya3ASw==; path=/; Domain=.adcirca.com x-cdn: Imperva x-iinfo: 13-40020391-40020392 NNNN CT(20 60 0) RT(1635920267104 0) q(0 0 0 5) r(1 1) U6 HTTP/2 200 cache-control: private content-length: 37259 content-type: text/html; charset=utf-8 server: Microsoft-IIS/10.0 set-cookie: ASP.NET_SessionId=2ay1twow0gipdvl2crq2px4q; path=/; HttpOnly; SameSite=Lax x-aspnet-version: 4.0.30319 x-powered-by: ASP.NET set-cookie: ARRAffinity=49a94ddcdeb25346ee3a2b6c760ba69b1e208509e94f78fe226be7730ca067b6;Path=/;HttpOnly;Secure;Domain=adcirca.com set-cookie: ARRAffinitySameSite=49a94ddcdeb25346ee3a2b6c760ba69b1e208509e94f78fe226be7730ca067b6;Path=/;HttpOnly;SameSite=None;Secure;Domain=adcirca.com date: Wed, 03 Nov 2021 06:17:46 GMT set-cookie: visid_incap_2149016=3Scg6p7HR4SWAd7P9zvwpospgmEAAAAAQUIPAAAAAAByuYrh7Y34A5HLLtkmlUkr; expires=Wed, 02 Nov 2022 06:34:01 GMT; HttpOnly; path=/; Domain=.adcirca.com set-cookie: nlbi_2149016=4ZE/VnVxnUPr7baaZIK6gQAAAADaqtxCPuoxm+pAiKSnviGR; path=/; Domain=.adcirca.com set-cookie: incap_ses_7221_2149016=hoH/GayUiCwDSxpUjyU2ZIspgmEAAAAADVOPP7T8QRIiaR47/iNoDg==; path=/; Domain=.adcirca.com x-cdn: Imperva x-iinfo: 13-40020405-40020392 PNNN RT(1635920267233 0) q(0 0 0 -1) r(0 0) U6 |
adcirca.com Whois Information
Domain Name: ADCIRCA.COM Registry Domain ID: 242361689_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.brandsight.com Registrar URL: http://brandsight.com Updated Date: 2021-10-02T23:00:41Z Creation Date: 2005-10-30T10:02:21Z Registry Expiry Date: 2022-10-30T09:02:21Z Registrar: GoDaddy Corporate Domains, LLC Registrar IANA ID: 3786 Registrar Abuse Contact Email: abuse@brandsight.com Registrar Abuse Contact Phone: +1 (518) 290-0169 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.MARKMONITOR.COM Name Server: NS2.MARKMONITOR.COM Name Server: NS3.MARKMONITOR.COM Name Server: NS4.MARKMONITOR.COM Name Server: NS5.MARKMONITOR.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-22T08:13:03Z <<< |